BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24818135)

  • 21. A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.
    Georgescu C; Corbin JM; Thibivilliers S; Webb ZD; Zhao YD; Koster J; Fung KM; Asch AS; Wren JD; Ruiz-Echevarría MJ
    BMC Cancer; 2019 May; 19(1):423. PubMed ID: 31060542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulated ECRG4 expression in breast cancer and its correlation with tumor progression and poor prognosis--A short Report.
    You Y; Li H; Qin X; Ran Y; Wang F
    Cell Oncol (Dordr); 2016 Feb; 39(1):89-95. PubMed ID: 26631111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlations of breast cancer FHIT gene with the incidence and prognosis of breast cancer.
    Fu Y; Shan X; Song W; Xu K; Jiao C; Zhang Q
    J BUON; 2019; 24(1):40-47. PubMed ID: 30941950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoter hypermethylation inactivate tumor suppressor FAM134B and is associated with poor prognosis in colorectal cancer.
    Islam F; Gopalan V; Pillai S; Lu CT; Kasem K; Lam AK
    Genes Chromosomes Cancer; 2018 May; 57(5):240-251. PubMed ID: 29318692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of breast cancer metastasis suppressor-1, BRMS-1, in human breast cancer and the biological impact of BRMS-1 on the migration of breast cancer cells.
    Zhang Y; Ye L; Tan Y; Sun P; Ji K; Jiang WG
    Anticancer Res; 2014 Mar; 34(3):1417-26. PubMed ID: 24596389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer.
    Sponziello M; Lavarone E; Pegolo E; Di Loreto C; Puppin C; Russo MA; Bruno R; Filetti S; Durante C; Russo D; Di Cristofano A; Damante G
    Endocrinology; 2013 Sep; 154(9):3043-53. PubMed ID: 23751876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-Cadherin mRNA Levels in Peripheral Blood Could Be a Potential Indicator of New Metastases in Breast Cancer: A Pilot Study.
    Masuda T; Ueo H; Kai Y; Noda M; Hu Q; Sato K; Fujii A; Hayashi N; Tsuruda Y; Otsu H; Kuroda Y; Eguchi H; Ohno S; Mimori K; Ueo H
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced expression of IQGAP2 and higher expression of IQGAP3 correlates with poor prognosis in cancers.
    Kumar D; Hassan MK; Pattnaik N; Mohapatra N; Dixit M
    PLoS One; 2017; 12(10):e0186977. PubMed ID: 29073199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P14ARF is down-regulated during tumour progression and predicts the clinical outcome in human breast cancer.
    Wazir U; Jiang WG; Yasaei H; Linne H; Newbold RF; Mokbel K
    Anticancer Res; 2013 May; 33(5):2185-9. PubMed ID: 23645774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer.
    Yang Y; Pospisil P; Iyer LK; Adelstein SJ; Kassis AI
    PLoS One; 2008; 3(11):e3661. PubMed ID: 18987750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of cancer/testis genes by database mining and mRNA expression analysis.
    Scanlan MJ; Gordon CM; Williamson B; Lee SY; Chen YT; Stockert E; Jungbluth A; Ritter G; Jäger D; Jäger E; Knuth A; Old LJ
    Int J Cancer; 2002 Apr; 98(4):485-92. PubMed ID: 11920606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated C1orf63 expression is correlated with CDK10 and predicts better outcome for advanced breast cancers: a retrospective study.
    Hong CQ; Zhang F; You YJ; Qiu WL; Giuliano AE; Cui XJ; Zhang GJ; Cui YK
    BMC Cancer; 2015 Jul; 15():548. PubMed ID: 26209438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
    Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
    BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered expression of the RON receptor tyrosine kinase in various epithelial cancers and its contribution to tumourigenic phenotypes in thyroid cancer cells.
    Wang MH; Lee W; Luo YL; Weis MT; Yao HP
    J Pathol; 2007 Dec; 213(4):402-11. PubMed ID: 17955509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers.
    Kashyap MK; Marimuthu A; Kishore CJ; Peri S; Keerthikumar S; Prasad TS; Mahmood R; Rao S; Ranganathan P; Sanjeeviah RC; Vijayakumar M; Kumar KV; Montgomery EA; Kumar RV; Pandey A
    Cancer Biol Ther; 2009 Jan; 8(1):36-46. PubMed ID: 18981721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
    Yang DC; Wang F; Elliott RL; Head JF
    Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes.
    Yang Q; Lin H; Wu S; Lei F; Zhu X; Song L; Hong M; Guo L
    PLoS One; 2015; 10(8):e0136448. PubMed ID: 26305455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of CHL1 gene during development of major human cancers.
    Senchenko VN; Krasnov GS; Dmitriev AA; Kudryavtseva AV; Anedchenko EA; Braga EA; Pronina IV; Kondratieva TT; Ivanov SV; Zabarovsky ER; Lerman MI
    PLoS One; 2011 Mar; 6(3):e15612. PubMed ID: 21408220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel visualized quantitative epigenetic imprinted gene biomarkers diagnose the malignancy of ten cancer types.
    Shen R; Cheng T; Xu C; Yung RC; Bao J; Li X; Yu H; Lu S; Xu H; Wu H; Zhou J; Bu W; Wang X; Si H; Shi P; Zhao P; Liu Y; Deng Y; Zhu Y; Zeng S; Pineda JP; Lin C; Zhou N; Bai C
    Clin Epigenetics; 2020 May; 12(1):71. PubMed ID: 32448196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and functional pathway analysis of nuclear receptor NR2F2 in ovarian cancer.
    Hawkins SM; Loomans HA; Wan YW; Ghosh-Choudhury T; Coffey D; Xiao W; Liu Z; Sangi-Haghpeykar H; Anderson ML
    J Clin Endocrinol Metab; 2013 Jul; 98(7):E1152-62. PubMed ID: 23690307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.